PerkinElmer this week reported that fourth-quarter revenues rose 20 percent, fueled by strong growth in its Life and Analytical Sciences segments. The company also said profits for the period climbed 26 percent.
 
President and newly-elected CEO Robert Friel said the company is “seeing more growth on the reagent side than the instrument side,” and as a result will “continue to drive new products particularly into the reagent area … particularly into our cell-based assays and GPCR screening.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.